FierceBiotech1d
Roche's Enhertu companion diagnostic secures new FDA approval in HER2-ultralow breast cancer
Roche has secured a new FDA approval for its first companion diagnostic test aimed at identifying breast cancer patients with ...
oncnursingnews1d
Common Adverse Events With Trastuzumab Deruxtecan for Breast Cancer
Given the evolving role of trastuzumab deruxtecan (Enhertu) in the treatment of breast cancer, especially those who are HER2 ...
‘Common Side Effects’ Creators Had to Make a Short to Convince Networks of Its ‘Totally New’ Tone
Common Side Effects co-creators Steve Hely and Joseph Bennett talk about process of making their new Adult Swim show.
FDA approval expands earlier use of Enhertu for metastatic breast cancer
The U.S. Food and Drug Administration has approved Enhertu (trastuzumab deruxtecan) for the treatment of adult patients with ...
How Weight-Loss Drugs Can Upend a Marriage
When Jeanne began to seriously consider taking Zepbound, one of the new-generation weight-loss drugs, she had the briefest of ...
Serious Ozempic Side Effects, Confirmed: Here’s What to Know
A study confirmed that side effects like pancreatitis and kidney damage are possible while taking GLP-1s like Ozempic. Here's ...
‘Common Side Effects’ Review: Adult Swim’s Animated Conspiracy Thriller About Big Pharma Is a Whole Vibe
Mike Judge and Greg Daniels executive produce the half-hour series about a rare mushroom with near-infinite healing properties, from creators Joe Bennett ('Scavengers Reign') and Steve Hely.
BioPharma Dive6d
Enhertu, with new OK, set to supplant chemo in HER2-low breast cancer
The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...